Autolus Therapeutics plc Forecast, price target & analysts
Autolus Therapeutics plc Target price 2025 - Analyst rating & recommendation
Autolus Therapeutics plc Classifications & Recommendation:
Autolus Therapeutics plc Price Target
| Target Price | $10.20 |
| Price | $1.50 |
| Potential |
580.00%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Autolus Therapeutics plc 2026 .
The average Autolus Therapeutics plc target price is $10.20.
This is
580.00%
register free of charge
$13.65
810.00%
register free of charge
$5.05
236.67%
register free of charge
|
|
| A rating was issued by 17 analysts: 16 Analysts recommend Autolus Therapeutics plc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Autolus Therapeutics plc stock has an average upside potential 2026 of
580.00%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 10.12 | 75.24 |
| 495.29% | 643.50% | |
| EBITDA Margin | -2,303.06% | -324.87% |
| 76.83% | 85.89% | |
| Net Margin | -2,180.43% | -311.92% |
| 82.21% | 85.69% |
13 Analysts have issued a sales forecast Autolus Therapeutics plc 2025 . The average Autolus Therapeutics plc sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Autolus Therapeutics plc EBITDA forecast 2025. The average Autolus Therapeutics plc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Autolus Therapeutics plc Analysts have issued a net profit forecast 2025. The average Autolus Therapeutics plc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.86 | -0.88 |
| 28.33% | 2.33% | |
| P/E | negative | |
| EV/Sales | 1.88 |
12 Analysts have issued a Autolus Therapeutics plc forecast for earnings per share. The average Autolus Therapeutics plc EPS is
This results in the following potential growth metrics and future valuations:
Autolus Therapeutics plc...
Current Autolus Therapeutics plc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Oct 20 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jul 21 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jun 12 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Apr 10 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Oct 20 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 13 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jul 21 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jun 12 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Apr 10 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 01 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
